Dunaieva I. Liraglutide as a means of modifying cardiometabolic risk in patients with arterial hypertension and concomitant obesity. IC [Internet]. 2025Apr.1 [cited 2026Mar.12];12(2):21-8. Available from: https://inter.knmu.edu.ua/article/view/10.35339.ic.2025.12.2.dun